Microbial Products Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00 – $ 8,900.00

Microbial Products Market: by Type (Enzymes, Polysaccharides, Nutrients, Chemotherapeutic Agents, Antibiotics, Others), by Source (Bacterial, Viral, Fungi, Others), by Application (Pharmaceutical, Diagnostic, Biotechnology, Others), by End User (Pharmaceutical and Biotechnological Industries, Hospitals and Clinics, Diagnostic Labs, Research and Academics, Others) and Geography

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Category: Healthcare

Description
Table Of Content
Company Profile

Report

Description

Microbial Products Market size is valued at USD 190.2 billion in 2021 and is expected to reach a value of USD 343.3 billion by 2028, growing at a CAGR of 8.8% during the forecast year 2022 to 2028. The global market provides a detailed overview and that can be segmented by type, source, application, and end-user. By type, the microbial product market has been segmented into enzymes, polysaccharides, nutrients, chemotherapeutic agents, antibiotics, and others. The enzymes segment is likely to be the largest and fastest-growing segment in terms of type. Further, nutrients are further segmented into amino acids, nucleotides, vitamins, organic acids, and others. Based on the source, the microbial products market is segmented into bacterial, viral, fungi and others. Among these, the bacterial segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on end user, the market is segmented into pharmaceutical and biotechnological industries, hospitals and clinics, diagnostic labs, research and academics and others. The pharmaceutical and biotechnological industries segment accounts for the largest share in 2021. The hospitals and clinics segment has the second-largest share during the forecast period 2021-2028.

Key Developments:

In April 2020, Sumitomo Chemicals invested USD 30 million in a joint venture with Conagen, a US-based biotechnology company.

Microbial Products Market

MARKET SUMMARY

8.8% CAGR

Study Period– 2022-2028
Base Year– 2021
CAGR– 8.8%
Largest Market– Asia-Pacific
Fastest Growing Market– North-America

Microbial Products Market

The Microbial Products Market report gives historical, current, and future market sizes (US$ Mn) based on by type, by application, source, end user and regions.
The Microbial Products Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Key Players

Amgen Inc.
Sanofi S.A
Novartis AG
Merck & Co. Inc.
Valent BioSciences Corp.

Microbial Products Market Growth

Over the anticipated years, the market is expected to benefit from the rising demand for healthcare nutrients such as vitamins, as well as the rising need for diagnostic microbiological goods. The production of enzymes for end-use industries such as food preservation, leather, and paper is expected to fuel market expansion over the forecast period.

North-America Got Significant Share

Microbial Products Market

By region, the North America microbial products market is expected to witness the highest market share during the forecast period It is attributed to favorable insurance penetration, excellent reimbursement policies, and massive healthcare expenditure in this region as the cause.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Features of the Report

The microbial products market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
The microbial products market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The microbial products market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The microbial products market report tracks recent innovations, key developments, and start-up details that are actively working in the market
The microbial products market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Microbial Products Market Segmentation

By Type

Enzymes,
Polysaccharides,
Nutrients,
Chemotherapeutic Agents,
Antibiotics,
Others

By Source

Bacterial,
Viral,
Fungi,
Others

By Application

Pharmaceutical,
Diagnostic,
Biotechnology,
Others

Location

GEOGRAPHY

Frequently Asked Questions

The microbial products market is projected to expand at a CAGR of 8.8% during the forecast period.

The major players in the global microbial products market are Kyowa Hakko Bio Co., GlaxoSmithKline plc, NovaDigm Therapeutics, Sanofi S.A, Novartis AG, Merck & Co. Inc., Valent BioSciences Corp., Amgen Inc., Pfizer Inc. Ltd, Biomérieux SA, Ajinomoto Co. Inc., and Locus FS.

Asia-Pacific is the fastest-growing region for microbial products market

Report

Table Of Content

1. Executive Summary

2. Global Microbial Products Market Introduction

2.1. Global Microbial Products Market – Taxonomy

2.2. Global Microbial Products Market –Definitions

2.2.1. Type

2.2.2. Source

2.2.3. Application

2.2.4. End User

3. Global Microbial Products Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Microbial Products Market Dynamic Factors – Impact Analysis

3.6. Global Microbial Products Market – Competition Landscape

4. Global Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028

4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Microbial Products Market, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.1. Enzymes

5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Polysaccharides

5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Nutrients

5.3.1. Amino Acids

5.3.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.1.3. Market Opportunity Analysis

5.3.2. Nucleotides

5.3.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.2.3. Market Opportunity Analysis

5.3.3. Vitamins

5.3.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.3.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3.3. Market Opportunity Analysis

5.3.4. Organic Acids

5.3.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.3.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.4.3. Market Opportunity Analysis

5.3.5. Others

5.3.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.3.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.5.3. Market Opportunity Analysis

5.4. Chemotherapeutic Agents

5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

5.5. Antibiotics

5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.5.3. Market Opportunity Analysis

5.6. Others

5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.6.3. Market Opportunity Analysis

6. Global Microbial Products Market Forecast, By Source, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.1. Bacterial

6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Viral

6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Fungi

6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Others

6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

7. Global Microbial Products Market Forecast, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.1. Pharmaceutical

7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Diagnostic

7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Biotechnology

7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Others

7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

8. Global Microbial Products Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.1. Pharmaceutical and Biotechnological Industries

8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Hospitals and Clinics

8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Diagnostic Labs

8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Research and Academics

8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Others

8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

9. Global Microbial Products Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.1. North America

9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Europe

9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Asia-Pacific

9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

9.4. Latin America

9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.4.3. Market Opportunity Analysis

9.5. Middle East and Africa

9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.5.3. Market Opportunity Analysis

9.6. Global Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Region, 2022 – 2028

10. North America Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

10.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Enzymes

10.1.2. Polysaccharides

10.1.3. Nutrients

10.1.3.1. Amino Acids

10.1.3.2. Nucleotides

10.1.3.3. Vitamins

10.1.3.4. Organic Acids

10.1.3.5. Others

10.1.4. Chemotherapeutic Agents

10.1.5. Antibiotics

10.1.6. Others

10.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. Bacterial

10.2.2. Viral

10.2.3. Fungi

10.2.4. Others

10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. Pharmaceutical

10.3.2. Diagnostic

10.3.3. Biotechnology

10.3.4. Others

10.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.4.1. Pharmaceutical and Biotechnological Industries

10.4.2. Hospitals and Clinics

10.4.3. Diagnostic Labs

10.4.4. Research and Academics

10.4.5. Others

10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.5.1. USA

10.5.2. Canada

10.6. North America Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Country, 2022 – 2028

10.7. North America Microbial Products Market Dynamics – Trends

11. Europe Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

11.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Enzymes

11.1.2. Polysaccharides

11.1.3. Nutrients

11.1.3.1. Amino Acids

11.1.3.2. Nucleotides

11.1.3.3. Vitamins

11.1.3.4. Organic Acids

11.1.3.5. Others

11.1.4. Chemotherapeutic Agents

11.1.5. Antibiotics

11.1.6. Others

11.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. Bacterial

11.2.2. Viral

11.2.3. Fungi

11.2.4. Others

11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Pharmaceutical

11.3.2. Diagnostic

11.3.3. Biotechnology

11.3.4. Others

11.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.4.1. Pharmaceutical and Biotechnological Industries

11.4.2. Hospitals and Clinics

11.4.3. Diagnostic Labs

11.4.4. Research and Academics

11.4.5. Others

11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.5.1. Germany

11.5.2. UK

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Russia

11.5.7. Poland

11.5.8. Rest of Europe

11.6. Europe Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Country, 2022 – 2028

11.7. Europe Microbial Products Market Dynamics – Trends

12. Asia-Pacific Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Enzymes

12.1.2. Polysaccharides

12.1.3. Nutrients

12.1.3.1. Amino Acids

12.1.3.2. Nucleotides

12.1.3.3. Vitamins

12.1.3.4. Organic Acids

12.1.3.5. Others

12.1.4. Chemotherapeutic Agents

12.1.5. Antibiotics

12.1.6. Others

12.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.2.1. Bacterial

12.2.2. Viral

12.2.3. Fungi

12.2.4. Others

12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1. Pharmaceutical

12.3.2. Diagnostic

12.3.3. Biotechnology

12.3.4. Others

12.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.4.1. Pharmaceutical and Biotechnological Industries

12.4.2. Hospitals and Clinics

12.4.3. Diagnostic Labs

12.4.4. Research and Academics

12.4.5. Others

12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.5.1. Japan

12.5.2. China

12.5.3. India

12.5.4. ASEAN

12.5.5. Australia & New Zealand

12.5.6. Rest of Asia-Pacific

12.6. Asia-Pacific Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Country, 2022 – 2028

12.7. Asia-Pacific Microbial Products Market Dynamics – Trends

13. Latin America Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

13.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Enzymes

13.1.2. Polysaccharides

13.1.3. Nutrients

13.1.3.1. Amino Acids

13.1.3.2. Nucleotides

13.1.3.3. Vitamins

13.1.3.4. Organic Acids

13.1.3.5. Others

13.1.4. Chemotherapeutic Agents

13.1.5. Antibiotics

13.1.6. Others

13.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.2.1. Bacterial

13.2.2. Viral

13.2.3. Fungi

13.2.4. Others

13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1. Pharmaceutical

13.3.2. Diagnostic

13.3.3. Biotechnology

13.3.4. Others

13.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.4.1. Pharmaceutical and Biotechnological Industries

13.4.2. Hospitals and Clinics

13.4.3. Diagnostic Labs

13.4.4. Research and Academics

13.4.5. Others

13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Argentina

13.5.4. Rest of Latin America

13.6. Latin America Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Country, 2022 – 2028

13.7. Latin America Microbial Products Market Dynamics – Trends

14. Middle East and Africa Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

14.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.1.1. Enzymes

14.1.2. Polysaccharides

14.1.3. Nutrients

14.1.3.1. Amino Acids

14.1.3.2. Nucleotides

14.1.3.3. Vitamins

14.1.3.4. Organic Acids

14.1.3.5. Others

14.1.4. Chemotherapeutic Agents

14.1.5. Antibiotics

14.1.6. Others

14.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.2.1. Bacterial

14.2.2. Viral

14.2.3. Fungi

14.2.4. Others

14.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.3.1. Pharmaceutical

14.3.2. Diagnostic

14.3.3. Biotechnology

14.3.4. Others

14.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.4.1. Pharmaceutical and Biotechnological Industries

14.4.2. Hospitals and Clinics

14.4.3. Diagnostic Labs

14.4.4. Research and Academics

14.4.5. Others

14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

14.5.1. Gulf Cooperation Council (GCC) Countries

14.5.2. Israel

14.5.3. South Africa

14.5.4. Rest of MEA

14.6. MEA Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Country, 2022 – 2028

14.7. MEA Microbial Products Market Dynamics – Trends

15. Competition Landscape

15.1. Strategic Dashboard of Top Market Players

15.2. Company Profiles (Introduction, Financial Analysis, Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)

15.2.1. Kyowa Hakko Bio Co.

15.2.2. GlaxoSmithKline plc

15.2.3. NovaDigm Therapeutics

15.2.4. Sanofi S.A

15.2.5. Novartis AG

15.2.6. Merck & Co. Inc.

15.2.7. Valent BioSciences Corp.

15.2.8. Amgen Inc.

15.2.9. Pfizer Inc. Ltd

15.2.10. Biomérieux SA

15.2.11. Ajinomoto Co. Inc.

15.2.12. Locus FS

16. Research Methodology

17. Key Assumptions and Acronyms

Description
Reviews (0)

Description

Key Developments:

In April 2020, Sumitomo Chemicals invested USD 30 million in a joint venture with Conagen, a US-based biotechnology company.

Reviews

There are no reviews yet.

Be the first to review “Microbial Products Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

search

Microbial Products Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

Description

Key Developments:

Microbial Products Market

Features of the Report

By Type

By Source

By Application

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Key Developments:

Reviews

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE